Kelsey Johnson v. HHS - Tdap, Guillain Barre Syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) (2019)

Kelsey Johnson filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she sustained Guillain-Barre Syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) caused by a Tdap vaccination received on April 2, 2015. She further alleged that she suffered residual effects for more than six months.

Respondent denied that the Tdap vaccine caused her conditions. Despite this denial, the parties filed a joint stipulation agreeing to an award of compensation.

The court found the stipulation reasonable and adopted it as the decision. The award included $18,329.81 to satisfy a lien from DXC Technology/TPL, $86,805.87 to satisfy a lien from MDwise, and a lump sum of $455,000.00 to petitioner for all remaining damages.

The total compensation awarded was $560,135.68. The decision was issued on September 11, 2019, based on a stipulation filed on June 20, 2019, with the petition having been filed on January 7, 2016.